221 related articles for article (PubMed ID: 28855137)
41. Lutein nanocrystals as antioxidant formulation for oral and dermal delivery.
Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
Int J Pharm; 2011 Nov; 420(1):141-6. PubMed ID: 21884768
[TBL] [Abstract][Full Text] [Related]
42. Development, characterization and evaluation of anti-fungal activity of miconazole based nanogel prepared from biodegradable polymer.
Farooq U; Rasul A; Sher M; Qadir MI; Nazir I; Mehmood Y; Riaz H; Shah PA; Jamil QA; Khan BA
Pak J Pharm Sci; 2020 Jan; 33(1(Special)):449-457. PubMed ID: 32173643
[TBL] [Abstract][Full Text] [Related]
43. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
[TBL] [Abstract][Full Text] [Related]
44. Feasibility of using collagen as the base of the antifungal drug, miconazole.
Yoshida K; Hirai K; Ara T; Ito M; Wang PL; Igarashi Y
J Oral Rehabil; 2006 May; 33(5):363-7. PubMed ID: 16629895
[TBL] [Abstract][Full Text] [Related]
45. Development of cellulosic polymer based gel of novel ternary mixture of miconazole nitrate for buccal delivery.
Rai VK; Yadav NP; Sinha P; Mishra N; Luqman S; Dwivedi H; Kymonil KM; Saraf SA
Carbohydr Polym; 2014 Mar; 103():126-33. PubMed ID: 24528709
[TBL] [Abstract][Full Text] [Related]
46. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.
Cerdeira AM; Mazzotti M; Gander B
Int J Pharm; 2010 Aug; 396(1-2):210-8. PubMed ID: 20600732
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine.
Perrins N; Howell SA; Moore M; Bond R
Vet Dermatol; 2005 Oct; 16(5):330-3. PubMed ID: 16238813
[TBL] [Abstract][Full Text] [Related]
48. Novel Cream Containing Microsponges of Anti-Acne Agent: Formulation Development and Evaluation.
Osmani RA; Aloorkar NH; Kulkarni AS; Kulkarni PK; Hani U; Thirumaleshwar S; Bhosale RR
Curr Drug Deliv; 2015; 12(5):504-16. PubMed ID: 25675339
[TBL] [Abstract][Full Text] [Related]
49. Biodirected synthesis of Miconazole-conjugated bacterial silver nanoparticles and their application as antifungal agents and drug delivery vehicles.
Kumar CG; Poornachandra Y
Colloids Surf B Biointerfaces; 2015 Jan; 125():110-9. PubMed ID: 25460601
[TBL] [Abstract][Full Text] [Related]
50. Rechargeable infection-responsive antifungal denture materials.
Cao Z; Sun X; Yeh CK; Sun Y
J Dent Res; 2010 Dec; 89(12):1517-21. PubMed ID: 20940361
[TBL] [Abstract][Full Text] [Related]
51. Hair follicle targeting with curcumin nanocrystals: Influence of the formulation properties on the penetration efficacy.
Pelikh O; Eckert RW; Pinnapireddy SR; Keck CM
J Control Release; 2021 Jan; 329():598-613. PubMed ID: 33011240
[TBL] [Abstract][Full Text] [Related]
52. Novel nanocrystal-based formulations of apremilast for improved topical delivery.
Parmar PK; Bansal AK
Drug Deliv Transl Res; 2021 Jun; 11(3):966-983. PubMed ID: 32588281
[TBL] [Abstract][Full Text] [Related]
53. Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs.
De Smet L; Saerens L; De Beer T; Carleer R; Adriaensens P; Van Bocxlaer J; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2014 May; 87(1):107-13. PubMed ID: 24388913
[TBL] [Abstract][Full Text] [Related]
54. Formulation and evaluation of miconazole lipogel for enhanced drug permeation.
Ahsan A; Waqar MA; Riaz T; Qureshi A; Butt MH; Ehsan M; Munir M; Tayyab S; Abid SZ
Pak J Pharm Sci; 2024 Jan; 37(1):95-105. PubMed ID: 38741405
[TBL] [Abstract][Full Text] [Related]
55. Nanoparticulated Systems Based on Natural Polymers Loaded with Miconazole Nitrate and Lidocaine for the Treatment of Topical Candidiasis.
Tejada G; Barrera MG; García P; Sortino M; Lamas MC; Lassalle V; Alvarez V; Leonardi D
AAPS PharmSciTech; 2020 Oct; 21(7):278. PubMed ID: 33033939
[TBL] [Abstract][Full Text] [Related]
56. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.
Bueno MG; Urban VM; Barbério GS; da Silva WJ; Porto VC; Pinto L; Neppelenbroek KH
Oral Dis; 2015 Jan; 21(1):57-65. PubMed ID: 24219354
[TBL] [Abstract][Full Text] [Related]
57. Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
Melkoumov A; Goupil M; Louhichi F; Raymond M; de Repentigny L; Leclair G
J Antimicrob Chemother; 2013 Sep; 68(9):2099-105. PubMed ID: 23620465
[TBL] [Abstract][Full Text] [Related]
58. The effects of miconazole on the ultrastructure of Candida albicans.
De Nollin S; Borgers M; Van Belle H
Proc R Soc Med; 1977; 70 Suppl 4(Suppl 4):19-23. PubMed ID: 122689
[No Abstract] [Full Text] [Related]
59. Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners.
Neppelenbroek KH; Lima JFM; Hotta J; Galitesi LL; Almeida ALPF; Urban VM
J Prosthodont; 2018 Feb; 27(2):177-181. PubMed ID: 29135059
[TBL] [Abstract][Full Text] [Related]
60. A novel concept for the treatment of couperosis based on nanocrystals in combination with solid lipid nanoparticles (SLN).
Pyo SM; Meinke M; Klein AF; Fischer TC; Müller RH
Int J Pharm; 2016 Aug; 510(1):9-16. PubMed ID: 27265313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
